WHITE PAPER

Treatment Selection in Autoimmune: How Digital Can Unlock Opportunities for Biopharma

Research insights into the biggest digital health opportunities for biopharma in biologics

It can be difficult to pair patients living with any chronic illness with the right treatment, but doctors treating autoimmune diseases face additional challenges. The diseases are complex, new treatments are hitting the market all the time, and doctors have to rely on patient self-reporting, which often gives an inaccurate picture of the patient's overall quality of life.

This white paper includes insights from leaders at top 10 biopharma companies and breaks down:

• The challenge of treatment selection
• The opportunity to leverage digital solutions
• The solutions that will benefit patients and providers alike

You'll also get access to a list of five ways digital enhances better treatment selection.

Biopharma and R&D